Long-term effects of cholesterol lowering and angiotension-converting enzyme inhibition on coronary atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). - SCAT

Description:

Long-term effects of cholesterol lowering and angiotension-converting enzyme inhibition on coronary atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).